Impress: A New Era in Orthodontics with €110 Million Boost
November 13, 2024, 3:37 pm
Location: Spain, Catalonia, Barcelona
Employees: 5001-10000
Founded date: 2019
Total raised: $349.89M
In the bustling streets of Barcelona, a revolution in orthodontics is underway. Impress, a trailblazer in invisible aligners, has secured over €110 million in funding. This investment, led by heavyweights like Trinity Capital Inc. and CareCapital, is more than just a financial boost. It’s a launchpad for expansion, innovation, and a vision to reshape orthodontic care across Europe.
Impress is not just another orthodontic chain. It stands tall as Europe’s largest player in the invisible aligner market. With this latest round of funding, the company is poised to solidify its dominance and reach new heights. The acquisition of DrSmile from the Straumann Group has already expanded its footprint in key markets like Germany, France, and the Netherlands. Now, with fresh capital, Impress is ready to spread its wings even further.
The company’s mission is clear: make high-quality orthodontic care accessible to everyone. They aim to open over 20 flagship clinics by 2025. Each new location will serve as a beacon of hope for those seeking a confident smile. Impress is not just about aesthetics; it’s about health, confidence, and well-being.
At the heart of Impress’s strategy is a commitment to digitalization. Their approach integrates cutting-edge technology with rigorous clinical oversight. This blend sets them apart in a crowded market. While many competitors falter, Impress thrives. Their model is built on medically supervised treatment plans, ensuring that every patient receives the care they deserve.
The orthodontic landscape is changing. Traditional methods are being challenged by innovative solutions. Impress is at the forefront of this shift. Their focus on patient-centered care, combined with advanced research and development, positions them as a leader in the health tech space. They are not just treating teeth; they are transforming lives.
With over 250,000 patients served annually, Impress is making waves. Their clinics span multiple countries, including Spain, Italy, Portugal, and the UK. Each clinic is a hub of innovation, where technology meets expertise. Patients can expect a seamless experience, from consultation to treatment.
The funding from Trinity Capital is a game-changer. It provides the liquidity needed to fuel growth and enhance operations. Impress is not just looking to expand its physical presence; it’s also investing in its technological backbone. This dual focus ensures that as they grow, they maintain the high standards that have become their hallmark.
Impress’s leadership understands the importance of adaptability. The orthodontic market is dynamic, with new challenges emerging regularly. By prioritizing effective, medically supervised treatments, Impress is not just surviving; it’s thriving. Their model is resilient, designed to withstand the pressures of a competitive landscape.
The acquisition of DrSmile is a strategic move that amplifies Impress’s capabilities. It allows them to tap into established markets and leverage existing resources. This synergy enhances their operational efficiency and accelerates their growth trajectory. Impress is not just expanding; it’s evolving.
As they look to the future, Impress is committed to innovation. Their proprietary software and treatment protocols are constantly being refined. This dedication to research and development ensures that they remain at the cutting edge of orthodontic care. Patients can trust that they are receiving the best possible treatment, backed by the latest advancements in technology.
The orthodontic industry is witnessing a paradigm shift. Patients are increasingly seeking alternatives to traditional braces. Impress is answering this call with a solution that is both effective and aesthetically pleasing. Their invisible aligners offer a discreet way to achieve a beautiful smile, without the hassle of metal brackets.
Impress’s growth is not just about numbers; it’s about impact. Each new clinic represents a chance to change lives. A confident smile can open doors, boost self-esteem, and enhance overall well-being. Impress understands this deeply. Their mission goes beyond business; it’s about making a difference in people’s lives.
The future looks bright for Impress. With over €110 million in funding, they are well-equipped to tackle the challenges ahead. Their vision of innovative, patient-centered orthodontic care is within reach. As they expand their network and enhance their services, they are set to redefine what orthodontics means in Europe.
In a world where health tech is rapidly evolving, Impress stands out as a beacon of hope. They are not just another company; they are pioneers in a new era of orthodontics. With each new clinic, they bring their vision closer to reality. The journey has just begun, and the possibilities are endless.
Impress is more than a name; it’s a promise. A promise of quality, accessibility, and transformation. As they continue to grow, one thing is clear: the future of orthodontics is in good hands.
Impress is not just another orthodontic chain. It stands tall as Europe’s largest player in the invisible aligner market. With this latest round of funding, the company is poised to solidify its dominance and reach new heights. The acquisition of DrSmile from the Straumann Group has already expanded its footprint in key markets like Germany, France, and the Netherlands. Now, with fresh capital, Impress is ready to spread its wings even further.
The company’s mission is clear: make high-quality orthodontic care accessible to everyone. They aim to open over 20 flagship clinics by 2025. Each new location will serve as a beacon of hope for those seeking a confident smile. Impress is not just about aesthetics; it’s about health, confidence, and well-being.
At the heart of Impress’s strategy is a commitment to digitalization. Their approach integrates cutting-edge technology with rigorous clinical oversight. This blend sets them apart in a crowded market. While many competitors falter, Impress thrives. Their model is built on medically supervised treatment plans, ensuring that every patient receives the care they deserve.
The orthodontic landscape is changing. Traditional methods are being challenged by innovative solutions. Impress is at the forefront of this shift. Their focus on patient-centered care, combined with advanced research and development, positions them as a leader in the health tech space. They are not just treating teeth; they are transforming lives.
With over 250,000 patients served annually, Impress is making waves. Their clinics span multiple countries, including Spain, Italy, Portugal, and the UK. Each clinic is a hub of innovation, where technology meets expertise. Patients can expect a seamless experience, from consultation to treatment.
The funding from Trinity Capital is a game-changer. It provides the liquidity needed to fuel growth and enhance operations. Impress is not just looking to expand its physical presence; it’s also investing in its technological backbone. This dual focus ensures that as they grow, they maintain the high standards that have become their hallmark.
Impress’s leadership understands the importance of adaptability. The orthodontic market is dynamic, with new challenges emerging regularly. By prioritizing effective, medically supervised treatments, Impress is not just surviving; it’s thriving. Their model is resilient, designed to withstand the pressures of a competitive landscape.
The acquisition of DrSmile is a strategic move that amplifies Impress’s capabilities. It allows them to tap into established markets and leverage existing resources. This synergy enhances their operational efficiency and accelerates their growth trajectory. Impress is not just expanding; it’s evolving.
As they look to the future, Impress is committed to innovation. Their proprietary software and treatment protocols are constantly being refined. This dedication to research and development ensures that they remain at the cutting edge of orthodontic care. Patients can trust that they are receiving the best possible treatment, backed by the latest advancements in technology.
The orthodontic industry is witnessing a paradigm shift. Patients are increasingly seeking alternatives to traditional braces. Impress is answering this call with a solution that is both effective and aesthetically pleasing. Their invisible aligners offer a discreet way to achieve a beautiful smile, without the hassle of metal brackets.
Impress’s growth is not just about numbers; it’s about impact. Each new clinic represents a chance to change lives. A confident smile can open doors, boost self-esteem, and enhance overall well-being. Impress understands this deeply. Their mission goes beyond business; it’s about making a difference in people’s lives.
The future looks bright for Impress. With over €110 million in funding, they are well-equipped to tackle the challenges ahead. Their vision of innovative, patient-centered orthodontic care is within reach. As they expand their network and enhance their services, they are set to redefine what orthodontics means in Europe.
In a world where health tech is rapidly evolving, Impress stands out as a beacon of hope. They are not just another company; they are pioneers in a new era of orthodontics. With each new clinic, they bring their vision closer to reality. The journey has just begun, and the possibilities are endless.
Impress is more than a name; it’s a promise. A promise of quality, accessibility, and transformation. As they continue to grow, one thing is clear: the future of orthodontics is in good hands.